Furthermore, increased levels of IL-6 may be a response to impaired IL-6 signaling [147], which is poorly defined in many clinical studies of obesity, insulin resistance, and diabetes. Here, IL6 is linked to obesity due to melanocortin 4 receptor deficiency.